Improved Quality of Life For Adult Lymphoma Patients Associated with Cellular Immunotherapy Treatment

Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy showed marked improvement on a variety of self-reported quality of life measures, according to a study published in Blood Advances. ....

Continue reading